Stockreport

Nkarta to Participate at Upcoming Investor Conferences

Nkarta, Inc.  (NKTX) 
PDF SOUTH SAN FRANCISCO, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell [Read more]